Catalyst Wire Dossier Catalyst Wire Dossier

5-Fluoro-2'-Deoxycytidine

5-fluoro-2'-deoxycytidine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 5-Fluoro-2'-Deoxycytidine, covering 2015-06-08 to 2015-06-08. Get the full timeline:

Most recent: Clinical Trial Update: 5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes [Phase 1]

See pricing